Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,098 | 769 | 38.8% |
| Grant | $22,642 | 3 | 38.0% |
| Travel and Lodging | $12,806 | 48 | 21.5% |
| Education | $1,007 | 10 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $30,934 | 132 | $0 (2024) |
| Abbott Laboratories | $6,363 | 169 | $0 (2024) |
| BIOTRONIK INC. | $5,428 | 34 | $0 (2024) |
| Boston Scientific Corporation | $5,215 | 66 | $0 (2024) |
| Biosense Webster, Inc. | $4,879 | 114 | $0 (2024) |
| Medtronic Vascular, Inc. | $913.83 | 24 | $0 (2020) |
| PFIZER INC. | $616.39 | 40 | $0 (2024) |
| Amgen Inc. | $479.19 | 32 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $402.01 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $399.15 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,046 | 209 | Abbott Laboratories ($2,561) |
| 2023 | $6,296 | 204 | Medtronic, Inc. ($2,232) |
| 2022 | $5,683 | 155 | Biosense Webster, Inc. ($1,614) |
| 2021 | $26,962 | 119 | Medtronic, Inc. ($24,795) |
| 2020 | $661.78 | 24 | Medtronic Vascular, Inc. ($184.36) |
| 2019 | $6,515 | 55 | Boston Scientific Corporation ($3,425) |
| 2018 | $2,041 | 37 | BIOTRONIK INC. ($781.53) |
| 2017 | $2,346 | 27 | BIOTRONIK INC. ($1,714) |
All Payment Transactions
830 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $288.89 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $196.80 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $36.66 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: Medical Device | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $39.65 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Electrophysiology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.84 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $43.06 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/26/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Medical Device | ||||||
| 11/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Biosense Webster, Inc. | QDOT MICRO Catheter (Device) | Food and Beverage | In-kind items and services | $11.50 | General |
| 11/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $82.54 | General |
| Category: General - Therapies_CRM | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $32.72 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $605.24 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 3,822 | 5,126 | $1.2M | $286,829 |
| 2022 | 19 | 752 | 829 | $181,404 | $47,753 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 283 | 518 | $178,960 | $44,961 | 25.1% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 51 | 51 | $146,370 | $34,140 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 182 | 182 | $81,718 | $20,288 | 24.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 51 | 51 | $68,340 | $18,534 | 27.1% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 27 | 27 | $57,753 | $15,554 | 26.9% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 20 | 20 | $46,560 | $13,184 | 28.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 247 | 247 | $47,918 | $12,336 | 25.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 75 | 75 | $43,153 | $10,912 | 25.3% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 49 | 49 | $48,265 | $10,755 | 22.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 105 | 112 | $41,104 | $9,968 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 143 | $27,742 | $8,020 | 28.9% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 22 | 22 | $24,002 | $7,192 | 30.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 87 | 282 | $20,304 | $7,075 | 34.8% |
| 33274 | Insertion of permanent leadless pacemaker using imaging guidance | Facility | 2023 | 21 | 21 | $27,321 | $6,844 | 25.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 823 | 955 | $28,650 | $5,783 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 314 | 557 | $33,420 | $5,458 | 16.3% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 24 | 24 | $23,712 | $5,332 | 22.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $20,271 | $4,795 | 23.7% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 12 | 12 | $18,000 | $4,631 | 25.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 51 | 232 | $15,776 | $4,447 | 28.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 75 | 76 | $20,292 | $4,225 | 20.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 150 | 183 | $14,823 | $3,942 | 26.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 199 | 247 | $21,489 | $3,601 | 16.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 24 | $10,458 | $3,125 | 29.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 97 | 158 | $7,584 | $2,299 | 30.3% |
About Dr. Thomas Flautt, D.O
Dr. Thomas Flautt, D.O is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1215342241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Flautt, D.O has received a total of $59,553 in payments from pharmaceutical and medical device companies, with $9,046 received in 2024. These payments were reported across 830 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($23,098).
As a Medicare-enrolled provider, Flautt has provided services to 4,574 Medicare beneficiaries, totaling 5,955 services with total Medicare billing of $334,582. Data is available for 2 years (2022–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Clinical Cardiac Electrophysiology
- Location Houston, TX
- Active Since 06/28/2014
- Last Updated 08/18/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215342241
Products in Payments
- AVEIR (Device) $3,619
- GENERAL THERAPIES (Device) $2,663
- CARTO 3 (Device) $1,901
- Arctic Front (Device) $1,596
- Carto 3 (Device) $1,179
- ELIQUIS (Drug) $720.10
- GENERAL - STRUCTURAL HEART (Device) $641.69
- Micra (Device) $558.47
- COBALT DR MRI SURESCAN (Device) $500.70
- MICRA (Device) $500.04
- LUX-Dx Insertable Cardiac Monitor (Device) $484.33
- Repatha (Biological) $466.88
- HawkOne (Device) $458.29
- PULSESELECT (Device) $439.38
- QDOT MICRO Catheter (Device) $416.19
- LifeVest (Device) $402.01
- XARELTO (Drug) $399.15
- ENSITE (Device) $387.63
- ENSITE PRECISION (Device) $358.43
- FORTIFY ASSURA (Device) $351.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947